<DOC>
	<DOCNO>NCT00420953</DOCNO>
	<brief_summary>Determine relative bioavailability PM101 I.V . Cordarone I.V .</brief_summary>
	<brief_title>Relative Bioavailability PM101 IV Cordarone IV</brief_title>
	<detailed_description />
	<mesh_term>Amiodarone</mesh_term>
	<criteria>Be healthy male female 18 59 year age , inclusive . Women childbearing potential must use medically acceptable form birth control duration trial must negative serum pregnancy test screen upon checkin study facility . Have BMI within range 1835 kg/m2 , inclusive . Be able communicate effectively study personnel . Have significant disease abnormal laboratory value determine medical history , physical examination laboratory evaluation , conduct screen visit admission clinic . Have normal 12lead electrocardiogram , without clinically significant abnormality rate , rhythm conduction include normal QTc segment time , i.e . &lt; 430 male &lt; 450 female . Be nonsmoker define smoke past 6 month prior dose . Be adequately informed nature risk study give write informed consent prior receive study medication . Known hypersensitivity allergy Cordarone I.V . excipients . Known hypersensitivity allergy iodine radioopaque dye . Women pregnant breast feeding . A history presence asthma pulmonary disease , thyroid disease ( hypo hyperthyroidism ) , hepatitis liver disease . Any disease condition ( medical surgical ) , opinion investigator , might compromise hematologic , cardiovascular , pulmonary , renal , gastrointestinal , hepatic , central nervous system ; condition may interfere absorption , distribution , metabolism excretion study drug , would place subject increase risk . The presence abnormal laboratory value consider clinically significant . Positive screen Hepatitis B ( HbsAg , Hepatitis B Surface Antigen ) , Hepatitis C ( anti HCV , Hepatitis C Antibody ) , HIV ( antiHIV 1/2 ) . Received investigational drug within period 30 day prior enrollment study . Received drug therapy within 2 week prior administration first dose studyrelated treatment . This exclusion extend 4 week drug know induce inhibit hepatic drug metabolism . Consumption alcohol within 48 hour prior dose administration inpatient period . A positive urine drug screen include ethanol , cocaine , THC , barbiturates , amphetamine , benzodiazepine , opiate . Any history alcohol abuse , illicit drug use ( use soft drug [ marijuana ] within 3 month prior screen visit hard drug [ cocaine , phencyclidine [ PCP ] crack ] within 1 year prior screen visit ) , significant mental illness , physical dependence opioid , history drug abuse addiction . A history difficulty donate blood . Donation plasma ( 500 mL ) within 7 day prior drug administration . Donation loss whole blood ( exclude volume blood drawn screening procedure study ) prior administration study medication follow : 50 mL 499 mL whole blood within 30 day , 499 mL whole blood within 56 day prior drug administration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>